Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

135.54
BATS BZX Real-Time Price
As of 9:43am ET
 +0.88 / +0.65%
Today’s Change
21.48
Today|||52-Week Range
156.93
+320.28%
Year-to-Date

Today’s Trading

Previous close134.66
Today’s openn.a.
Day’s range-- - --
Volume6,240
Average volume (3 months)871,906
Market cap$5.9B
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)-198.10%
Earnings growth (this year)+43.67%
Earnings growth (next 5 years)+61.30%
Revenue growth (last year)+20.07%
P/E ratioNM
Price/Sales65.86
Price/Book73.92

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+1.71+1.28%
OPKOPKO Health Inc-0.05-0.44%
SGENSeattle Genetics Inc+0.09+0.22%
IDXXIDEXX Laboratories I...+0.40+0.55%
Data as of 9:44am ET, 09/03/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$20.7M
Annual profit (last year)-$87.1M
Net profit margin-421.28%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul L. Berns
Chief Financial Officer &
Executive Vice President
Graeme Bell
Corporate headquarters
Palo Alto, California

Forecasts

Partner Offers